Diversified Healthcare Trust 6.25% Senior Notes Due 2046 (DHCNL) Financials
Newest figures come from the 10-Q for Q3 FY2026, filed Nov 2, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the DHCNL SEC filings page.
Diversified Healthcare Trust 6.25% Senior Notes Due 2046 (DHCNL) reported $1.5B in revenue over the twelve months to Sep 30, 2026, down 3.8% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings.
Revenue is edging higher, but shrinking assets, cash deficits, and heavy leverage define a capital-intensive business.
FY2025 revenue grew2.8% and the net margin improved6.2 percentage points , yet that accounting improvement did not translate into cash: operating cash flow swung from$112M to-$20M , while free cash flow remained negative. The divergence indicates that reported earnings are being shaped by non-cash items or timing effects more than by cash-producing operations.
The balance sheet contracted, with assets down
Capital expenditures were
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed: here 4 of 6, with the others left out rather than counted as zero. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Diversified Healthcare Trust 6.25% Senior Notes Due 2046's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Diversified Healthcare Trust 6.25% Senior Notes Due 2046's revenue grew a modest 2.8% year-over-year to $1.5B. This slow but positive growth earns a score of 46/100.
Diversified Healthcare Trust 6.25% Senior Notes Due 2046 has a moderate D/E ratio of 1.47. This balance of debt and equity financing earns a leverage score of 37/100.
Not available for Diversified Healthcare Trust 6.25% Senior Notes Due 2046, so it is left out of the overall score, which averages the 4 of 6 dimensions that can be computed.
Diversified Healthcare Trust 6.25% Senior Notes Due 2046's operations used $19.6M of cash, and capex of $146.8M added to the outflow, for a free cash flow shortfall of $166.4M. This results in a cash flow score of 13/100.
Not available for Diversified Healthcare Trust 6.25% Senior Notes Due 2046, so it is left out of the overall score, which averages the 4 of 6 dimensions that can be computed.
Diversified Healthcare Trust 6.25% Senior Notes Due 2046 passes 4 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 2 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, the one computable operating efficiency signal (asset turnover improving) passes.
Diversified Healthcare Trust 6.25% Senior Notes Due 2046 reported a net loss of $285.9M while operations used $19.6M of cash. With neither figure positive, the ratio between the two carries no quality signal.
Key Financial Metrics
Earnings & Revenue
Diversified Healthcare Trust 6.25% Senior Notes Due 2046 generated $367.7M in revenue in Q3 2026. This represents a decrease of 5.4% from the same quarter a year earlier. Against the prior quarter it is up 0.6%.
Diversified Healthcare Trust 6.25% Senior Notes Due 2046 reported a net loss of $50.2M in Q3 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
Diversified Healthcare Trust 6.25% Senior Notes Due 2046 earned -$0.21 per diluted share (EPS) in Q3 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
Not reported for Q3 2026.
Cash & Balance Sheet
Diversified Healthcare Trust 6.25% Senior Notes Due 2046 generated $521K in free cash flow in Q3 2026, representing cash available after capex. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. Against the prior quarter it is down 96.3%.
Diversified Healthcare Trust 6.25% Senior Notes Due 2046 held $110.7M in cash against $2.4B in long-term debt as of Q3 2026.
Diversified Healthcare Trust 6.25% Senior Notes Due 2046 paid $0.01 per share in dividends in Q3 2026. That is unchanged from the same quarter a year earlier. It is unchanged from the prior quarter.
Margins & Returns
Diversified Healthcare Trust 6.25% Senior Notes Due 2046's net profit margin was -13.7% in Q3 2026, showing the share of revenue converted to profit. This is up 28.5 percentage points from the same quarter a year earlier. Against the prior quarter it is down 3.4 percentage points.
Diversified Healthcare Trust 6.25% Senior Notes Due 2046's quarterly ROE was -3.3% in Q3 2026: one quarter's net income over shareholder equity, not annualized. This is up 6.4 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.9 percentage points.
Not reported for Q3 2026.
Not reported for Q3 2026.
Capital Allocation
Diversified Healthcare Trust 6.25% Senior Notes Due 2046 spent $2.6M on share buybacks in Q3 2026, returning capital to shareholders by reducing shares outstanding. This represents an increase of 168.4% from the same quarter a year earlier. Against the prior quarter it is up 5022.0%.
Diversified Healthcare Trust 6.25% Senior Notes Due 2046 invested $26.9M in capex in Q3 2026, funding long-term assets and infrastructure. This represents a decrease of 33.7% from the same quarter a year earlier. Against the prior quarter it is up 11.1%.
Not reported for Q3 2026.
DHCNL Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'25Filing | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'24Filing |
|---|---|---|---|---|---|---|---|---|
| Revenue | $367.7M-5.4% | $365.4M-4.5% | $366.5M-5.3% | $379.6M0.0% | $388.7M+4.0% | $382.7M+3.0% | $386.9M+4.3% | $379.6M+5.0% |
| SG&A Expenses | $14.6M+14.5% | $19.3M+73.0% | $14.0M+56.0% | $12.5M | $12.8M-8.2% | $11.2M+78.5% | $9.0M+18.9% | N/A |
| Interest Expense | $37.2M-24.0% | $37.1M-27.2% | $37.0M-35.9% | $46.9M-21.3% | $48.9M-17.8% | $50.9M-13.2% | $57.8M+0.4% | $59.5M+21.8% |
| Income Tax | $724K+114.8% | $1.3M+53.9% | $622K+1169.4% | $514Kn/m | $337K+127.7% | $843K+395.9% | $49K-73.8% | -$38K-157.6% |
| Net Income | -$50.2Mn/m | -$37.4Mn/m | -$43.3Mn/m | -$21.2Mn/m | -$164.0Mn/m | -$91.6Mn/m | -$9.0Mn/m | -$87.4Mn/m |
| EPS (Basic) | -$0.21n/m | -$0.16n/m | -$0.18n/m | -$0.09n/m | -$0.68n/m | -$0.38n/m | -$0.04n/m | -$0.37n/m |
| EPS (Diluted) | -$0.21n/m | -$0.16n/m | -$0.18n/m | -$0.09n/m | -$0.68n/m | -$0.38n/m | -$0.04n/m | -$0.37n/m |
| Diluted Shares (Avg) | 241M+0.2% | 241M+0.3% | 241M+0.3% | N/A | 240M+0.3% | 240M+0.3% | 240M+0.3% | N/A |
Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, Operating Income, EBITDA.
DHCNL Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'25Filing | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'24Filing |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $4.2B-10.6% | $4.2B-10.9% | $4.3B-14.6% | $4.4B-15.1% | $4.7B-11.4% | $4.8B-10.8% | $5.0B-6.6% | $5.1B-5.7% |
| Cash & Equivalents | $110.7M-45.0% | $116.8M-17.6% | $121.8M-59.8% | $105.4M-27.1% | $201.4M-21.5% | $141.8M-46.6% | $302.6M+46.1% | $144.6M-41.2% |
| Total Liabilities | $2.7B-11.2% | $2.7B-8.5% | $2.6B-13.1% | $2.7B-15.2% | $3.0B-7.5% | $2.9B-8.9% | $3.0B-1.7% | $3.2B+2.2% |
| Long-Term Debt | $2.4B | $2.4B | $2.4B | $2.4B-19.9% | N/A | N/A | N/A | $3.1B |
| Total Equity | $1.5B-9.4% | $1.6B-14.7% | $1.6B-16.8% | $1.7B-15.0% | $1.7B-17.6% | $1.9B-13.7% | $1.9B-13.4% | $2.0B-16.2% |
| Retained Earnings | $991.2M-13.3% | $1.0B-20.3% | $1.1B-22.9% | $1.1B-20.3% | $1.1B-23.5% | $1.3B-18.0% | $1.4B-17.3% | $1.4B-20.8% |
Not reported in any period shown, so not listed: Current Assets, Short-Term Investments, Inventory, Accounts Receivable, Long-Term Investments, Goodwill, Current Liabilities, Non-Current Liabilities.
DHCNL Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'25Filing | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'24Filing |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $27.4Mn/m | $38.4M-27.6% | $8.3Mn/m | -$20.1M-210.5% | -$49.3M-333.2% | $53.0M+19.7% | -$3.2M-111.3% | $18.2Mn/m |
| Depreciation & Amortization | $62.9M-3.8% | $62.5M-5.6% | $62.9M-7.9% | $62.0M-20.0% | $65.3M-5.3% | $66.3M-3.1% | $68.3M-2.6% | $77.5M-7.3% |
| Capital Expenditures | $26.9M-33.7% | $24.2M-29.2% | $35.2M-11.3% | $32.4M-51.4% | $40.6M-14.2% | $34.2M-16.6% | $39.6M-15.1% | $66.7M+0.2% |
| Free Cash Flow | $521Kn/m | $14.2M-24.6% | -$26.8Mn/m | -$52.5Mn/m | -$89.8Mn/m | $18.8M+471.7% | -$42.9Mn/m | -$48.5Mn/m |
| Investing Cash Flow | -$26.9M-539.4% | -$38.7Mn/m | $13.6M-95.3% | $207.4Mn/m | $6.1Mn/m | -$21.1Mn/m | $291.1Mn/m | -$66.1Mn/m |
| Financing Cash Flow | -$5.8M-105.5% | -$3.3Mn/m | -$3.9Mn/m | -$275.1Mn/m | $104.2Mn/m | -$190.0M-448.8% | -$131.0Mn/m | -$63.6M-341.6% |
| Dividends Paid | $2.4M+0.3% | $2.4M+0.3% | $2.4M+0.3% | $2.4M+0.3% | $2.4M+0.3% | $2.4M+0.4% | $2.4M+0.4% | $2.4M+0.4% |
| Share Buybacks | $2.6M+168.4% | $50K-51.5% | $88K+1366.7% | $82K+4000.0% | $954K+22.2% | $103K+139.5% | $6K-92.3% | $2K-71.4% |
Not reported in any period shown, so not listed: Stock-Based Compensation.
DHCNL Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'25Filing | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'24Filing |
|---|---|---|---|---|---|---|---|---|
| Net Margin | -13.7%+28.5pp | -10.2%+13.7pp | -11.8%-9.5pp | -5.6%+17.4pp | -42.2%-15.8pp | -23.9%+2.4pp | -2.3%+20.9pp | -23.0%+5.3pp |
| Return on Equity | -3.3%+6.4pp | -2.4%+2.6pp | -2.7%-2.2pp | -1.3%+3.2pp | -9.7%-4.9pp | -4.9%-0.4pp | -0.5%+3.4pp | -4.5%-0.1pp |
| Return on Assets | -1.2%+2.3pp | -0.9%+1.1pp | -1.0%-0.8pp | -0.5%+1.2pp | -3.5%-1.6pp | -1.9%-0.1pp | -0.2%+1.4pp | -1.7%+0.2pp |
| Debt-to-Equity | 1.60 | 1.54 | 1.51 | 1.47-0.1x | N/A | N/A | N/A | 1.56 |
| Liabilities-to-Equity | 1.740.0x | 1.68+0.1x | 1.63+0.1x | 1.620.0x | 1.77+0.2x | 1.56+0.1x | 1.56+0.2x | 1.62+0.3x |
| Asset Turnover | 0.090.0x | 0.090.0x | 0.090.0x | 0.090.0x | 0.080.0x | 0.080.0x | 0.080.0x | 0.070.0x |
| FCF Margin | 0.1%+23.3pp | 3.9%-1.0pp | -7.3%+3.8pp | -13.8%-1.0pp | -23.1%-16.1pp | 4.9%+4.0pp | -11.1%-6.2pp | -12.8%+7.6pp |
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Current Ratio.
Where Diversified Healthcare Trust 6.25% Senior Notes Due 2046 Ranks
Frequently Asked Questions
Diversified Healthcare Trust 6.25% Senior Notes Due 2046 (DHCNL) reported $1.5B in total revenue for fiscal year 2025. This represents a 2.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
Diversified Healthcare Trust 6.25% Senior Notes Due 2046 (DHCNL) revenue grew by 2.8% year-over-year, from $1.5B to $1.5B in fiscal year 2025.
No, Diversified Healthcare Trust 6.25% Senior Notes Due 2046 (DHCNL) reported a net loss of $152.1M over the trailing 12 months to September 30, 2026. In fiscal year 2025 it reported a net loss of $285.9M, with a net profit margin of -18.6%.
As of fiscal year 2025, Diversified Healthcare Trust 6.25% Senior Notes Due 2046 (DHCNL) had $105.4M in cash and equivalents against $2.4B in long-term debt.
Diversified Healthcare Trust 6.25% Senior Notes Due 2046 (DHCNL) had a net profit margin of -18.6% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
Yes, Diversified Healthcare Trust 6.25% Senior Notes Due 2046 (DHCNL) paid $0.04 per share in dividends during fiscal year 2025.
Diversified Healthcare Trust 6.25% Senior Notes Due 2046 (DHCNL) has a return on equity of -17.2% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
Diversified Healthcare Trust 6.25% Senior Notes Due 2046 (DHCNL) recorded an outflow of $166.4M in free cash flow during fiscal year 2025. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
Diversified Healthcare Trust 6.25% Senior Notes Due 2046 (DHCNL) recorded an outflow of $19.6M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
Diversified Healthcare Trust 6.25% Senior Notes Due 2046 (DHCNL) had $4.4B in total assets as of fiscal year 2025, including both current and long-term assets.
Diversified Healthcare Trust 6.25% Senior Notes Due 2046 (DHCNL) invested $146.8M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
Diversified Healthcare Trust 6.25% Senior Notes Due 2046 (DHCNL) had a debt-to-equity ratio of 1.47 as of fiscal year 2025. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.
Diversified Healthcare Trust 6.25% Senior Notes Due 2046 (DHCNL) had a liabilities-to-equity ratio of 1.62 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.
Diversified Healthcare Trust 6.25% Senior Notes Due 2046 (DHCNL) had a return on assets of -6.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
Diversified Healthcare Trust 6.25% Senior Notes Due 2046 (DHCNL) has a Piotroski F-Score of 4 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Diversified Healthcare Trust 6.25% Senior Notes Due 2046 (DHCNL) reported a net loss of $285.9M while operations used $19.6M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Diversified Healthcare Trust 6.25% Senior Notes Due 2046 (DHCNL) scores 28 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is the average of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. For Diversified Healthcare Trust 6.25% Senior Notes Due 2046 it averages the 4 of 6 dimensions that can be computed; the others are left out rather than counted as zero. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.